Influx Healthtech Ltd. announces “GLP-1 Support Nutrition” supplements for the new Semaglutide era in India
With the launch of Ozempic (semaglutide) in India, GLP-1 medicines have officially entered mainstream clinical practice for Type 2 diabetes management—bringing with them a big opportunity and a big responsibility: medication works best when nutrition is planned, not accidental. GLP-1 therapies are powerful because they help improve glycaemic control and…




